The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Dry Eye Disease Market Research Report 2024

Global Dry Eye Disease Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1413443

No of Pages : 99

Ask Your Query
Synopsis
Dry eye disease is a multifactorial disease which is characterized by insufficiency of tears in eye. Insufficient lubrication in eye lead to burning, sensing, redness and pain in eye.
The global Dry Eye Disease market was valued at US$ 2397.5 million in 2023 and is anticipated to reach US$ 2949.6 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.
North American market for Dry Eye Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dry Eye Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dry Eye Disease include Santen Pharma, Novartis, Llergan, Takeda, TRB Chemedica, Sun Pharmaceutical, Senju Pharmaceutical, Sentiss Pharma and Johnson & Johnson, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dry Eye Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Eye Disease.
Report Scope
The Dry Eye Disease market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dry Eye Disease manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Santen Pharma
Novartis
Llergan
Takeda
TRB Chemedica
Sun Pharmaceutical
Senju Pharmaceutical
Sentiss Pharma
Johnson & Johnson
Otsuka
Mitotech
FCI
Altacor
Valeant Pharmaceuticals
United Laboratories
Jianfeng Group
Eusan GMBH
Segment by Type
Artificial Tears
Anti-inflammatory Drugs
Other
Segment by Application
Hospital
Drug Stores
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dry Eye Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dry Eye Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Dry Eye Disease Market Overview
1.1 Product Overview and Scope of Dry Eye Disease
1.2 Dry Eye Disease Segment by Type
1.2.1 Global Dry Eye Disease Market Value Comparison by Type (2024-2030)
1.2.2 Artificial Tears
1.2.3 Anti-inflammatory Drugs
1.2.4 Other
1.3 Dry Eye Disease Segment by Application
1.3.1 Global Dry Eye Disease Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.4 Global Dry Eye Disease Market Size Estimates and Forecasts
1.4.1 Global Dry Eye Disease Revenue 2019-2030
1.4.2 Global Dry Eye Disease Sales 2019-2030
1.4.3 Global Dry Eye Disease Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dry Eye Disease Market Competition by Manufacturers
2.1 Global Dry Eye Disease Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dry Eye Disease Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dry Eye Disease Average Price by Manufacturers (2019-2024)
2.4 Global Dry Eye Disease Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dry Eye Disease, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dry Eye Disease, Product Type & Application
2.7 Dry Eye Disease Market Competitive Situation and Trends
2.7.1 Dry Eye Disease Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dry Eye Disease Players Market Share by Revenue
2.7.3 Global Dry Eye Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dry Eye Disease Retrospective Market Scenario by Region
3.1 Global Dry Eye Disease Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dry Eye Disease Global Dry Eye Disease Sales by Region: 2019-2030
3.2.1 Global Dry Eye Disease Sales by Region: 2019-2024
3.2.2 Global Dry Eye Disease Sales by Region: 2025-2030
3.3 Global Dry Eye Disease Global Dry Eye Disease Revenue by Region: 2019-2030
3.3.1 Global Dry Eye Disease Revenue by Region: 2019-2024
3.3.2 Global Dry Eye Disease Revenue by Region: 2025-2030
3.4 North America Dry Eye Disease Market Facts & Figures by Country
3.4.1 North America Dry Eye Disease Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dry Eye Disease Sales by Country (2019-2030)
3.4.3 North America Dry Eye Disease Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dry Eye Disease Market Facts & Figures by Country
3.5.1 Europe Dry Eye Disease Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dry Eye Disease Sales by Country (2019-2030)
3.5.3 Europe Dry Eye Disease Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dry Eye Disease Market Facts & Figures by Country
3.6.1 Asia Pacific Dry Eye Disease Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dry Eye Disease Sales by Country (2019-2030)
3.6.3 Asia Pacific Dry Eye Disease Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dry Eye Disease Market Facts & Figures by Country
3.7.1 Latin America Dry Eye Disease Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dry Eye Disease Sales by Country (2019-2030)
3.7.3 Latin America Dry Eye Disease Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dry Eye Disease Market Facts & Figures by Country
3.8.1 Middle East and Africa Dry Eye Disease Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dry Eye Disease Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dry Eye Disease Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dry Eye Disease Sales by Type (2019-2030)
4.1.1 Global Dry Eye Disease Sales by Type (2019-2024)
4.1.2 Global Dry Eye Disease Sales by Type (2025-2030)
4.1.3 Global Dry Eye Disease Sales Market Share by Type (2019-2030)
4.2 Global Dry Eye Disease Revenue by Type (2019-2030)
4.2.1 Global Dry Eye Disease Revenue by Type (2019-2024)
4.2.2 Global Dry Eye Disease Revenue by Type (2025-2030)
4.2.3 Global Dry Eye Disease Revenue Market Share by Type (2019-2030)
4.3 Global Dry Eye Disease Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dry Eye Disease Sales by Application (2019-2030)
5.1.1 Global Dry Eye Disease Sales by Application (2019-2024)
5.1.2 Global Dry Eye Disease Sales by Application (2025-2030)
5.1.3 Global Dry Eye Disease Sales Market Share by Application (2019-2030)
5.2 Global Dry Eye Disease Revenue by Application (2019-2030)
5.2.1 Global Dry Eye Disease Revenue by Application (2019-2024)
5.2.2 Global Dry Eye Disease Revenue by Application (2025-2030)
5.2.3 Global Dry Eye Disease Revenue Market Share by Application (2019-2030)
5.3 Global Dry Eye Disease Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Santen Pharma
6.1.1 Santen Pharma Corporation Information
6.1.2 Santen Pharma Description and Business Overview
6.1.3 Santen Pharma Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Santen Pharma Dry Eye Disease Product Portfolio
6.1.5 Santen Pharma Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Dry Eye Disease Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Llergan
6.3.1 Llergan Corporation Information
6.3.2 Llergan Description and Business Overview
6.3.3 Llergan Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Llergan Dry Eye Disease Product Portfolio
6.3.5 Llergan Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Corporation Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Takeda Dry Eye Disease Product Portfolio
6.4.5 Takeda Recent Developments/Updates
6.5 TRB Chemedica
6.5.1 TRB Chemedica Corporation Information
6.5.2 TRB Chemedica Description and Business Overview
6.5.3 TRB Chemedica Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.5.4 TRB Chemedica Dry Eye Disease Product Portfolio
6.5.5 TRB Chemedica Recent Developments/Updates
6.6 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Corporation Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sun Pharmaceutical Dry Eye Disease Product Portfolio
6.6.5 Sun Pharmaceutical Recent Developments/Updates
6.7 Senju Pharmaceutical
6.6.1 Senju Pharmaceutical Corporation Information
6.6.2 Senju Pharmaceutical Description and Business Overview
6.6.3 Senju Pharmaceutical Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Senju Pharmaceutical Dry Eye Disease Product Portfolio
6.7.5 Senju Pharmaceutical Recent Developments/Updates
6.8 Sentiss Pharma
6.8.1 Sentiss Pharma Corporation Information
6.8.2 Sentiss Pharma Description and Business Overview
6.8.3 Sentiss Pharma Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sentiss Pharma Dry Eye Disease Product Portfolio
6.8.5 Sentiss Pharma Recent Developments/Updates
6.9 Johnson & Johnson
6.9.1 Johnson & Johnson Corporation Information
6.9.2 Johnson & Johnson Description and Business Overview
6.9.3 Johnson & Johnson Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Johnson & Johnson Dry Eye Disease Product Portfolio
6.9.5 Johnson & Johnson Recent Developments/Updates
6.10 Otsuka
6.10.1 Otsuka Corporation Information
6.10.2 Otsuka Description and Business Overview
6.10.3 Otsuka Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Otsuka Dry Eye Disease Product Portfolio
6.10.5 Otsuka Recent Developments/Updates
6.11 Mitotech
6.11.1 Mitotech Corporation Information
6.11.2 Mitotech Dry Eye Disease Description and Business Overview
6.11.3 Mitotech Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Mitotech Dry Eye Disease Product Portfolio
6.11.5 Mitotech Recent Developments/Updates
6.12 FCI
6.12.1 FCI Corporation Information
6.12.2 FCI Dry Eye Disease Description and Business Overview
6.12.3 FCI Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.12.4 FCI Dry Eye Disease Product Portfolio
6.12.5 FCI Recent Developments/Updates
6.13 Altacor
6.13.1 Altacor Corporation Information
6.13.2 Altacor Dry Eye Disease Description and Business Overview
6.13.3 Altacor Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Altacor Dry Eye Disease Product Portfolio
6.13.5 Altacor Recent Developments/Updates
6.14 Valeant Pharmaceuticals
6.14.1 Valeant Pharmaceuticals Corporation Information
6.14.2 Valeant Pharmaceuticals Dry Eye Disease Description and Business Overview
6.14.3 Valeant Pharmaceuticals Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Valeant Pharmaceuticals Dry Eye Disease Product Portfolio
6.14.5 Valeant Pharmaceuticals Recent Developments/Updates
6.15 United Laboratories
6.15.1 United Laboratories Corporation Information
6.15.2 United Laboratories Dry Eye Disease Description and Business Overview
6.15.3 United Laboratories Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.15.4 United Laboratories Dry Eye Disease Product Portfolio
6.15.5 United Laboratories Recent Developments/Updates
6.16 Jianfeng Group
6.16.1 Jianfeng Group Corporation Information
6.16.2 Jianfeng Group Dry Eye Disease Description and Business Overview
6.16.3 Jianfeng Group Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Jianfeng Group Dry Eye Disease Product Portfolio
6.16.5 Jianfeng Group Recent Developments/Updates
6.17 Eusan GMBH
6.17.1 Eusan GMBH Corporation Information
6.17.2 Eusan GMBH Dry Eye Disease Description and Business Overview
6.17.3 Eusan GMBH Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Eusan GMBH Dry Eye Disease Product Portfolio
6.17.5 Eusan GMBH Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dry Eye Disease Industry Chain Analysis
7.2 Dry Eye Disease Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dry Eye Disease Production Mode & Process
7.4 Dry Eye Disease Sales and Marketing
7.4.1 Dry Eye Disease Sales Channels
7.4.2 Dry Eye Disease Distributors
7.5 Dry Eye Disease Customers
8 Dry Eye Disease Market Dynamics
8.1 Dry Eye Disease Industry Trends
8.2 Dry Eye Disease Market Drivers
8.3 Dry Eye Disease Market Challenges
8.4 Dry Eye Disease Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock